BMS's 2013 looking up as Eliquis launch gears up

Matthew Arnold

January 24 2013

Bristol-Myers Squibb issued relatively upbeat guidance for 2013, but much depends on the performance of Eliquis.

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.